Role of the cerebro-placental-uterine ratio in predicting adverse perinatal outcome in low-risk pregnancies at term.


Journal

Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 28 06 2022
accepted: 29 07 2022
medline: 17 7 2023
pubmed: 30 8 2022
entrez: 29 8 2022
Statut: ppublish

Résumé

The cerebroplacental ratio (CPR) is associated with adverse perinatal outcome (APO) in low-risk pregnancies near term. A Doppler parameter, which also includes information from the uterine vessels could potentially improve detection of subclinical placental dysfunction. The aim of this study is to investigate the performance of cerebro-placental-uterine ratio (CPUR) related to APO prediction in low-risk term pregnancies in > 40 + 0 weeks. This is a retrospective cohort study. All low-risk pregnancies in which feto-maternal Doppler was examined from 40 + 0 weeks and an appropriate for gestational age fetus was present were included. ROC (receiver operating characteristic curves) analyses were performed to assess the predictive value of CPUR. The presence of at least one of the following outcome parameters was defined as composite APO (CAPO): operative delivery (OD) due to intrapartum fetal compromise (IFC), admission to the neonatal intensive care unit, umbilical cord arterial pH ≤ 7.15, 5 min APGAR ≤ 7. A total of n = 114 cases were included. Mean gestational age at examination and delivery were 40 + 3 weeks and 40 + 6 weeks, respectively. Overall, CAPO occurred in 38 of 114 cases (33.3%). ROC analyses showed a significant association of CPUR (AUC = 0.67, p = 0.004) and CPR (AUC = 0.68, p = 0.002) with CAPO. Additionally, CPUR (AUC = 0.64, p = 0.040) showed a predictive value for OD due to IFC. The CPUR in > 40 + 0 weeks showed a predictive value for CAPO and OD due to IFC in low-risk pregnancies. However, the extent to which CPUR can be used to optimize delivery management warrants further investigations in prospective interventional studies.

Identifiants

pubmed: 36038657
doi: 10.1007/s00404-022-06733-8
pii: 10.1007/s00404-022-06733-8
pmc: PMC10349005
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

849-855

Informations de copyright

© 2022. The Author(s).

Références

Ultrasound Obstet Gynecol. 2018 Sep;52(3):340-346
pubmed: 28594099
Ultrasound Obstet Gynecol. 2019 Apr;53(4):465-472
pubmed: 30353583
Ultrasound Obstet Gynecol. 2018 Mar;51(3):313-322
pubmed: 28708272
Acta Obstet Gynecol Scand. 2021 Oct;100(10):1910-1916
pubmed: 34212368
Ultrasound Obstet Gynecol. 2018 Mar;51(3):381-386
pubmed: 28294442
Int J Gynaecol Obstet. 2015 Oct;131(1):13-24
pubmed: 26433401
Ultrasound Obstet Gynecol. 2008 Aug;32(2):128-32
pubmed: 18457355
Br J Obstet Gynaecol. 1987 Dec;94(12):1150-5
pubmed: 3322373
Ultraschall Med. 2023 Feb;44(1):50-55
pubmed: 34058782
Ultrasound Obstet Gynecol. 2006 Nov;28(6):809-13
pubmed: 17019746
Am J Obstet Gynecol. 2013 Feb;208(2):124.e1-6
pubmed: 23159689
Am J Obstet Gynecol. 2015 Jul;213(1):5-15
pubmed: 26113227
Geburtshilfe Frauenheilkd. 2021 Aug;81(8):870-895
pubmed: 34393254
Am J Obstet Gynecol. 2017 Jun;216(6):606.e1-606.e10
pubmed: 28189607
Am J Obstet Gynecol. 2015 Jul;213(1):54.e1-54.e10
pubmed: 25446667
Fetal Diagn Ther. 2020;47(1):34-44
pubmed: 31137027
Ultrasound Obstet Gynecol. 2019 Sep;54(3):367-375
pubmed: 30338593
JAMA. 2013 Jun 19;309(23):2445-6
pubmed: 23645117
Ultraschall Med. 2019 Jun;40(3):319-325
pubmed: 30895584
Placenta. 2017 Jun;54:68-75
pubmed: 28216258
N Engl J Med. 2018 Aug 09;379(6):513-523
pubmed: 30089070
BMJ. 2019 Nov 20;367:l6131
pubmed: 31748223
Ultrasound Obstet Gynecol. 2015 Feb;45(2):156-61
pubmed: 25123254
Ultrasound Obstet Gynecol. 2019 Apr;53(4):481-487
pubmed: 29900608
Geburtshilfe Frauenheilkd. 2022 Jul 07;82(7):719-726
pubmed: 35815096
Ultrasound Obstet Gynecol. 2021 Aug;58(2):331-339
pubmed: 34278615

Auteurs

Oliver Graupner (O)

Department of Obstetrics and Gynecology, University Hospital Aachen, RWTH Aachen University, Pauwelsstraße, 30 52074, Aachen, Germany. ograupner@ukaachen.de.
Department of Obstetrics and Gynecology, University Hospital Rechts Der Isar, Technical University, Munich, Germany. ograupner@ukaachen.de.

Markus Meister (M)

Department of Obstetrics and Gynecology, University Hospital Aachen, RWTH Aachen University, Pauwelsstraße, 30 52074, Aachen, Germany.

Linda Lecker (L)

Department of Obstetrics and Gynecology, University Hospital Aachen, RWTH Aachen University, Pauwelsstraße, 30 52074, Aachen, Germany.

Sepideh Karim-Payab (S)

Department of Obstetrics and Gynecology, University Hospital Aachen, RWTH Aachen University, Pauwelsstraße, 30 52074, Aachen, Germany.

Cordula Franz (C)

Department of Obstetrics and Gynecology, University Hospital Aachen, RWTH Aachen University, Pauwelsstraße, 30 52074, Aachen, Germany.

Juliane Carow (J)

Department of Obstetrics and Gynecology, University Hospital Aachen, RWTH Aachen University, Pauwelsstraße, 30 52074, Aachen, Germany.

Christian Enzensberger (C)

Department of Obstetrics and Gynecology, University Hospital Aachen, RWTH Aachen University, Pauwelsstraße, 30 52074, Aachen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH